GGrantIndex
Sort

40,608 grants matching prostate cancer

Genomics and Predictive Modeling of Prostate Cancer Heath Disparity

$357,686
Harry Ostrer · Albert Einstein College Of Medicine · U01 · FY2011 · CA

HIFU and Immunotherapy Treatment of Metastatic Prostate Cancer

$357,671
Narendra T Sanghvi · Focus Surgery, Inc. · R44 · FY2009 · CA

Enhancing anti-neoplastic activity of metformin in prostate cancer

$357,624
Xiaoqi Liu · Purdue University · R01 · FY2017 · CA

Lung Cancer Drivers and Dependencies as Therapeutic Targets

$357,605
Scott W Lowe · Sloan-Kettering Inst Can Research · P01 · FY2014 · CA

Effects of Radiation on Brain Microvasculature and Cognition

$357,599
William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2014 · NS

Targeted Drug Delivery

$357,587
Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2014 · CA

Molecular Signatures of STAT Regulated Genes in Cancer

$357,435
City Of Hope/Beckman Research Institute · R01 · FY2005 · CA

Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer

$357,405
Christopher Michael McNair · Thomas Jefferson University · R01 · FY2020 · CA

Targeting Cell Cycle Alterations to Improve Treatment for Advanced Prostate Cancer

$357,405
Christopher Michael McNair · Thomas Jefferson University · R01 · FY2021 · CA

Sodium Channel Blockers as Inhibitors of Prostate Cancer

$357,396
University Of Virginia Charlottesville · R01 · FY2004 · CA

Quantitative Mass Spectrometry

$357,373
Kenneth Tomer · National Institute Of Environmental Health Sciences · Z01 · FY2008 · ES

Consequences and mechanism of aberrant splicing in African American prostate cancer disparities

$357,354
Norman H Lee · George Washington University · R01 · FY2021 · CA

Consequences and mechanism of aberrant splicing in African American prostate cancer disparities

$357,354
Norman H Lee · George Washington University · R01 · FY2020 · CA

Project 3: Developing CAR T Cell Therapies to Target Tumor Heterogeneity in Advanced Prostate Cancer

$357,342
Owen N Witte · University Of California Los Angeles · P50 · FY2019 · CA

DNA damage signaling to immune checkpoints

$357,312
Christopher J. Bakkenist · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · CA

TARGETING NEUROMIMICRY IN PROSTATE CANCER METASTASIS

$357,309
Cedars-Sinai Medical Center · · FY2015 · Department of the Army

Survival and Recurrence of Dormant Cancer Cells

$357,238
Lewis A Chodosh · University Of Pennsylvania · R01 · FY2019 · CA

ANGIOCIDIN, A NEW ANGIOGENESIS INHIBITOR

$357,061
Temple University · R01 · FY2004 · CA

Novel Molecular Profiling of Prostate Cancer Signatures

$357,033
Shao-Yao Ying · University Of Southern California · R01 · FY2006 · CA

Omega-3 PUFA-gene interaction in prostate cancer

$357,010
Yong Q Chen · Wake Forest University Health Sciences · R01 · FY2012 · CA

Project 3 Topological mapping of chromatin architectures for hormone-independent gene transcription

$357,000
Victor Jin · University Of Texas Hlth Science Center · U54 · FY2020 · CA

Therapeutic targeting Wnt5A signaling for advanced prostate cancer

$356,964
Allen C Gao · University Of California At Davis · R01 · FY2024 · CA

Nanotherapeutics for Synergistic Targeting of Myc in Prostate Cancer

$356,960
Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA

Nanotherapeutics for Synergistic Targeting of Myc in Prostate Cancer

$356,960
Song Li · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · CA

Smart nanoparticles regulating oncogenic IncRNA for breast cancer therapy

$356,947
Zheng-Rong Lu · Case Western Reserve University · R01 · FY2020 · CA